ClinicalTrials.Veeva

Menu

Daptomycin Concentration in Drainage Fluid and Blood Samples of ICU Patients

U

University Hospital Tuebingen

Status

Completed

Conditions

Heart Assist Device

Treatments

Drug: Daptomycin

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

10 patients with chronic heart failure receiving daptomycin therapy after implantation of a left ventricular heart assist system. Measurement of daptomycin levels in drainage fluids (mediastinal and pleural drainage systems) and in blood samples.

Enrollment

9 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • written consent
  • heart assist device implantation
  • wound drainage
  • daptomycin therapy

Exclusion criteria

  • pregnancy
  • no written consent possible
  • absence of wound drainage
  • allergy to study medication
  • acute rhabdomyolysis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems